OTCMKTS:ESMC Escalon Medical Q2 2025 Earnings Results & Report $0.15 0.00 (0.00%) As of 10/9/2026 Escalon Medical reported Q2 2025 earnings on February 14, 2025. The company reported EPS of $0.02, while revenue was $3.22 million. Research:ProfileEarnings History Earnings Announcement Details QuarterQ2 2025Report DateFebruary 14, 2025TimeAfter Market Closes Escalon Medical EPS ResultsActual EPS$0.02Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEscalon Medical Revenue ResultsActual Revenue$3.22 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Escalon Medical Q2 2025 Earnings FAQ Did Escalon Medical beat earnings estimates for Q2 2025? Escalon Medical (OTCMKTS:ESMC) reported earnings of $0.02 per share for Q2 2025. The report was announced on Friday, February 14, 2025. What was Escalon Medical's revenue for Q2 2025? Escalon Medical reported revenue of $3.22 million for Q2 2025. Escalon Medical Earnings HeadlinesEscalon Medical CorpOctober 10 at 11:47 AM | markets.ft.comEscalon Medical (OTCMKTS:ESMC) Stock Price Crosses Below 50 Day Moving Average - Should You Sell?October 9 at 3:41 AM | americanbankingnews.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 10 at 1:00 AM | Stansberry Research (Ad)Escalon Medical (OTCMKTS:ESMC) Stock Breaks Above Fifty Day Moving Average - Here's What HappenedOctober 1, 2026 | americanbankingnews.comEscalon Medical Delays Annual 10-K FilingSeptember 28, 2026 | tipranks.comESCALON MEDICAL CORP by Escalon Medical Corp. Insider Trading Activity | OTC:ESMC | BenzingaJuly 13, 2026 | benzinga.comSee More Escalon Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Escalon Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Escalon Medical and other key companies, straight to your email. Email Address About Escalon MedicalEscalon Medical (OTCMKTS:ESMC) is a medical-device company focused on products for the ophthalmic surgical market. The company develops, manufactures and markets devices and related products used by eye-care professionals, particularly in procedures involving the retina and vitreous. Its product offerings have included ophthalmic surgical instruments, delivery systems and products used in retinal surgery, such as intraocular gases, silicone oils and other retinal tamponade materials. These products are designed to support procedures for treating retinal detachments and other serious eye conditions. Escalon Medical has historically served ophthalmic surgeons and medical institutions through markets in the United States and internationally. Publicly available information about the company’s current operations, leadership and geographic reach is limited, and its product portfolio and corporate structure may have changed over time.View Escalon Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
